Broker Tips
BT Group 'looks cheap' but more clarity needed, says Morgan Stanley
BT Group "looks cheap" on a sum-of-the-parts valuation, suggested Morgan Stanley, retaining its 'equal-weight' rating due some lingering reservations.
Mediclinic double upgraded to 'buy' by Jefferies on UAE potential
Shares in global hospital manager Mediclinic International gained more than 4% on Thursday after the company was upgraded to ‘buy’ from ‘underperform’ by analysts at Jefferies.
Thursday broker round-up
Thomas Cook: Berenberg downgrades to Sell with a target price of 100p.
Indivior should soar on FDA approval for opioid treatment
Anticipating the US drug regulator to announce the approval of Indivior’s monthly injection for the treatment of opioid-use disorder by Thursday evening, analysts predict shares in the pharma company could surge around 20% on the news.
Goldman removes Babcock from Conviction List after H1 results
Goldman Sachs has removed engineering and outsourcing group Babcock International from its Conviction List following the company's first-half results, in which it cut FY19 growth to the low end of its mid-single digit target range due to delays in some land government contracts.